Patient demographics and disease history: intent to treat population (n=65)
| Tenovil 4 μg/kg QD (n=22) | Tenovil 8 μg/kg TIW (n=21) | Pooled placebo (n=22) | |
| Age (y) | 33 | 32 | 31 |
| Sex ratio (F/M) | 68/32 | 67/33 | 68/32 |
| CD duration (y) | 5 | 5 | 5 |
| Age at CD onset <30 y (%) | 45 | 43 | 45 |
| Disease location (n) | |||
| Colon | 2 | 3 | 3 |
| Ileum | 22 | 21 | 22 |
| Reason for resection (%) | |||
| Fibrostenosis | 59 | 62 | 54.5 |
| Obstruction | 23 | 9.5 | 27 |
| Fistula/abscess | 0 | 14 | 9.5 |
| Disease activity | 23 | 33 | 18 |
| Anastomosis end to end (%) | 100 | 90 | 100 |
| Smoking history (continue) (%) | 23 | 38 | 18 |
CD, Crohn's disease.